Epanolol
| Epanolol | |
|---|---|
| Epanolol_synthesis.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Epanolol is a beta-adrenergic blocker used primarily in the treatment of hypertension and angina pectoris. It is a selective beta-1 adrenergic receptor antagonist, which means it primarily affects the heart and reduces its workload by slowing down the heart rate and decreasing the force of contraction.
Pharmacology[edit]
Epanolol works by blocking the action of epinephrine and norepinephrine on the beta-1 adrenergic receptors in the heart. This action leads to a decrease in heart rate, cardiac output, and blood pressure, making it effective in managing conditions like hypertension and angina.
Mechanism of Action[edit]
Epanolol selectively binds to beta-1 adrenergic receptors, which are predominantly found in cardiac tissue. By inhibiting these receptors, epanolol reduces the effects of sympathetic nervous system stimulation, leading to decreased heart rate and myocardial contractility.
Clinical Uses[edit]
Epanolol is primarily used in the management of:
It may also be used off-label for other cardiovascular conditions where beta-blockade is beneficial.
Side Effects[edit]
Common side effects of epanolol include:
Less common but more serious side effects can include:
- Heart failure
- Bronchospasm in patients with asthma
Synthesis[edit]
The synthesis of epanolol involves several chemical reactions, as depicted in the accompanying diagram. The process typically starts with the preparation of the appropriate aromatic amine, followed by a series of reactions to introduce the necessary functional groups and achieve the final beta-blocker structure.
